Applied Precision develops and manufactures high-resolution and super-resolution microscopy instruments with software and data visualization tools that together provide scientists with detailed information on the structure and behavior of live and fixed cells.
Applied Precision’s proprietary technologies are complementary to GE Healthcare‘s IN Cell Analyzer Systems which are used for high-throughput sub-cellular analysis in cell biology research.
GE Healthcare Life Sciences president and CEO Kieran Murphy said the combination of the company’s expertise in cell science together with the great talent of the team at Applied Precision will help them drive development of new technologies and create an extensive offering across the full spectrum of cell biology research.
GE Healthcare plans to retain the Applied Precision facility in Issaquah, Washington state.
The acquisition, which is subject to customary closing conditions including regulatory approvals, is expected to close in Q2 2011.
